BICX - BioCorRx Inc.

0.3075
0.064   20.878%

Share volume: 2
Last Updated: 05-06-2026
Healthcare/Services – Health: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.24
0.06
0.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 43%
Dept financing 43%
Liquidity 1%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0.75%
3 Months
2.50%
6 Months
-29.15%
1 Year
-1.16%
2 Year
-25.00%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
$0.31 - $0.31
EPS 
-$0.40
52 WEEK RANGE
$0.20 - $0.50
52 WEEK CHANGE
-$3.91
MARKET CAP 
3.851 M
YIELD 
N/A
SHARES OUTSTANDING 
23.685 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$29
AVERAGE 30 VOLUME 
$405
Company detail
CEO:
Region: US
Website: biocorrx.com
Employees: 0
IPO year: 2014
Issue type:
Market: OTCM
Industry: Healthcare/Services – Health
Sector: Services

BioCorRx Inc. develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant. UnCraveRx also develops BICX101, an injectable product; and BICx104, an implantable implant for the treatment of opioid addiction and alcoholism.

Recent news